In the second of a series of blogs on the coronovirus outbreak, the authors sound a note of cautious optimism: "We hope for a relatively optimistic outlook for the COVID-19 pandemic in the United States, with the quick realization of all modifying interventions: earlier and broader testing, strict preventive hygienic and societal measures, a safe and effective vaccine, and effective therapies to treat the virus." Read more at the Baker Institute Blog.
Hagop M. Kantarjian, Leonard ZwellingMarch 19, 2020
The COVID-19 outbreak has now reached pandemic proportions, threatening the health of millions worldwide and adversely affecting the international economy. Understanding the status of COVID-19, its potential impact in the U.S., and the needed preventive measures could save many lives.
Hagop M. Kantarjian, Leonard ZwellingMarch 12, 2020
Products containing hemp extracts high in CBD are gaining mainstream popularity, acceptance and federal legality. In this article, Lisa Pittman, nonresident fellow in drug policy, focuses on litigation issues particular to hemp.
According to the authors, as a leading agricultural state, Texas is poised to become the new leader in hemp production, whether for medicinal or industrial purposes.
President Trump's plan to designate Mexican drugs cartels as foreign terrorist organizations is a mistake, says nonresident fellow Gary Hale. Read why in the Baker Institute Blog.
According to the authors, developments in cannabis law, arbitration clause interpretation and the economic loss doctrine show that numerous facets of business litigation are changing rapidly.
Baker Institute director Edward P. Djerejian, former ambassador to Israel and to Syria, appeared on Al-Jazeera's "From Washington"
program to discuss the possible consequences of Jamal Khashoggi's disappearance (Arabic): https://youtu.be/J7-xALrG_3s.